🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/03/2015 | 56,69 | 56,97 | 55,83 | 55,94 | -0,17% | 2,00% | 13.692.434 |
| 23/03/2015 | 55,73 | 56,43 | 55,38 | 56,04 | +0,26% | 1,88% | 11.170.108 |
| 20/03/2015 | 55,57 | 56,16 | 55,11 | 55,90 | +0,64% | 1,89% | 27.367.472 |
| 19/03/2015 | 54,80 | 55,67 | 54,42 | 55,54 | +0,97% | 2,28% | 15.149.783 |
| 18/03/2015 | 53,81 | 55,31 | 53,64 | 55,01 | +2,09% | 3,12% | 15.645.068 |
| 17/03/2015 | 54,28 | 54,28 | 53,66 | 53,88 | -1,14% | 1,14% | 10.479.371 |
| 16/03/2015 | 53,99 | 54,69 | 53,99 | 54,50 | +1,64% | 1,31% | 12.073.798 |
| 13/03/2015 | 53,46 | 53,85 | 53,09 | 53,63 | +0,05% | 1,41% | 13.700.399 |
| 12/03/2015 | 53,26 | 53,65 | 53,11 | 53,60 | +0,20% | 1,00% | 13.576.106 |
| 11/03/2015 | 54,86 | 54,86 | 53,41 | 53,49 | -0,92% | 2,64% | 16.417.234 |
| 10/03/2015 | 54,34 | 54,57 | 53,90 | 53,99 | -1,19% | 1,23% | 13.755.000 |
| 09/03/2015 | 54,24 | 54,74 | 53,72 | 54,64 | +0,74% | 1,88% | 8.742.416 |
| 06/03/2015 | 55,20 | 55,22 | 54,12 | 54,24 | -1,97% | 1,99% | 11.595.806 |
| 05/03/2015 | 55,43 | 55,61 | 55,15 | 55,32 | +0,17% | 0,83% | 12.087.737 |
| 04/03/2015 | 55,73 | 55,96 | 55,04 | 55,23 | -0,79% | 1,66% | 13.975.290 |
| 03/03/2015 | 55,95 | 56,01 | 55,30 | 55,67 | -0,41% | 1,28% | 8.647.362 |
| 02/03/2015 | 55,86 | 56,19 | 55,61 | 55,90 | +0,07% | 1,04% | 10.131.226 |
| 27/02/2015 | 56,19 | 56,36 | 55,81 | 55,86 | -0,71% | 0,97% | 13.686.775 |
| 26/02/2015 | 55,97 | 56,44 | 55,97 | 56,26 | +0,80% | 0,84% | 12.040.577 |
| 25/02/2015 | 55,78 | 56,27 | 55,40 | 55,81 | +0,22% | 1,56% | 8.861.050 |
| 24/02/2015 | 55,81 | 55,89 | 55,39 | 55,69 | +0,10% | 0,89% | 8.084.377 |
| 23/02/2015 | 55,72 | 55,98 | 55,51 | 55,63 | -0,09% | 0,86% | 9.002.215 |
| 20/02/2015 | 55,49 | 55,80 | 55,09 | 55,68 | +0,09% | 1,29% | 12.161.830 |
| 19/02/2015 | 56,15 | 56,29 | 55,16 | 55,63 | -0,85% | 2,01% | 10.308.338 |
| 18/02/2015 | 55,98 | 56,31 | 55,56 | 56,11 | +0,02% | 1,33% | 11.039.842 |
| 17/02/2015 | 56,05 | 56,27 | 56,01 | 56,10 | -0,03% | 0,46% | 10.676.290 |
| 13/02/2015 | 56,20 | 56,24 | 55,93 | 56,12 | -0,12% | 0,56% | 8.278.466 |
| 12/02/2015 | 56,30 | 56,40 | 55,91 | 56,18 | +0,24% | 0,88% | 7.553.670 |
| 11/02/2015 | 56,07 | 56,26 | 55,73 | 56,05 | -0,19% | 0,95% | 10.987.127 |
| 10/02/2015 | 56,30 | 56,62 | 56,08 | 56,15 | +0,89% | 0,97% | 9.997.291 |